[1]符雨嫣 王海银 罗雅双 程文迪 金春林.上海市医疗机构国谈药品遴选与评价指标体系研究[J].中国卫生质量管理,2024,31(08):087-91.[doi:10.13912/j.cnki.chqm.2024.31.8.17]
　FU Yuyan,WANG Haiyin,LUO Yashuang.A National Negotiated Drug Selection and Evaluation Index System for Medical Institutions in Shanghai[J].Chinese Health Quality Management,2024,31(08):087-91.[doi:10.13912/j.cnki.chqm.2024.31.8.17]
点击复制

上海市医疗机构国谈药品遴选与评价指标体系研究()
分享到：

《中国卫生质量管理》[ISSN:1006-7515/CN:CN 61-1283/R]

卷:
第31卷
期数:
2024年08期
页码:
087-91
栏目:
卫生技术评估专栏
出版日期:
2024-08-15

文章信息/Info

Title:
A National Negotiated Drug Selection and Evaluation Index System for Medical Institutions in Shanghai
作者:
符雨嫣 王海银 罗雅双 程文迪 金春林
上海市卫生和健康发展研究中心（上海市医学科学技术情报研究所）
Author(s):
FU Yuyan; WANG Haiyin; LUO Yashuang
Shanghai Health Development Research Center (Shanghai Institute of Medical Science and Technology Information)
关键词:
德尔菲法; 医疗机构; 国谈药品; 遴选评价
Keywords:
Delphi; Medical Institutions; National Negotiated Drug; Selection and Evaluation
分类号:
R197.3；R9
DOI:
10.13912/j.cnki.chqm.2024.31.8.17
文献标志码:
A
摘要:
目的探索构建医疗机构国谈药品遴选与评价指标体系，为医疗机构药品准入提供评价工具。方法通过现状调研和文献回顾，构建指标体系框架，邀请上海市20家医疗机构药剂科主任进行两轮咨询，采用层次分析法计算各级指标权重。结果形成了包含4个一级指标、8个二级指标、17个三级指标的国谈药品遴选与评价指标体系。两轮咨询专家积极系数分别为80%、100%，专家权威系数为0.90；两轮专家咨询的三级指标重要性评分变异系数均值分别为0.138、0.107，可获得性评分变异系数均值分别为0.167、0.133。进院需求、临床价值、经济价值、医院管理4个一级指标权重分别为29.99%、38.20%、15.40%、16.41%。结论构建的上海市医疗机构国谈药品遴选与评价指标体系具有一定科学性，可为医疗机构药品准入管理提供工具支持。
Abstract:
ObjectiveTo explore the establishment of a selection and evaluation index system for national negotiated drug in medical institutions, and to provide evaluation tool for drug access in medical institutions.MethodsBased on the current situation investigation and literature review, the index system framework was constructed, and 20 pharmacy directors from Shanghai medical institutions were invited to conduct two rounds of consultation, and the weights of indicators at all levels were calculated using analytic hierarchy process.ResultsA national negotiated drug selection and evaluation index system consisting of 4 first-level indexes, 8 second-level indexes and 17 third-level indexes was formed. The positive coefficients of experts in the two rounds of consultation were 80%, 100%, and the coefficient of expert authority was 0.90. For the two rounds of expert consultation, the mean coefficient of variation of the importance score were 0.138 and 0.107,and the mean coefficient of variation of the accessibility score were 0.167 and 0.133, respectively. The weights of the four first-level indicators of admission demand, clinical value, economic value and hospital management were 29.99%, 38.20%, 15.40% and 16.41%, respectively.Conclusion The established index system of national negotiated drug selection and evaluation in Shanghai medical institutions is scientific and can provide tools for drug access management in medical institutions.

参考文献/References:

［1］国家药品监督管理局.2021年度药品审评报告［EB/OL］.(2021-06-01)［2024-01-08］. http://www.cnpharm.com/c/2022-06-01/827272.shtml.［2］中国药学会.中国医保药品管理改革进展与成效蓝皮书［EB/OL］. (2021-10-01)［2024-01-08］.https://www.sohu.com/a/604612762_121015326.［3］国家医疗保障局,国家卫生健康委.关于适应国家医保谈判常态化持续做好谈判药品落地工作的通知：医保函〔2021〕182号［EB/OL］.(2021-09-09)［2024-01-08］.https://www.gov.cn/zhengce/zhengceku/202 1-09/11/content_5636762.htm. ［4］国务院办公厅.关于推动公立医院高质量发展的意见：国办发〔2021〕18号［EB/OL］.(2021-06-04)［2024-01-08］. http://www.gov.cn/zhengce/content/2021-06/04/content_5615473.htm.［5］上海市卫生和计划生育委员会，上海市人力资源和社会保障局，上海市医疗保险办公室.上海市医疗机构药事管理与药物治疗学委员会管理规定［EB/OL］. (2017-09-15)［2024-01-08］. https://www.shanghai.gov.cn/nw42237/20200823/0001-42237_1266107.html.［6］ALMEIDA ND, MINES L, NICOLAU I, et al. A framework for aiding the translation of scientific evidence into policy: the experience of a hospital-based technology assessment unit［J］. International Journal of Technology Assessment in Health Care, 2019，35（3）:204-211.［7］MARTELLI N,HANSEN P,VAN DEN BRINK H，et al. Combining multi-criteria decision analysis and mini-health technology assessment: a funding decision-support tool for medical devices in a university hospital setting［J］. Journal of Biomedical Informatics，2016 (59) ：201-208. ［8］SAMPIETRO-COLOM L, MORILLA-BACHS I, GUTIERREZ-MORENO S, et al. Development and test of a decision support tool for hospital health technology assessment［J］. International Journal of Technology Assessment in Health Care, 2012, 28(4):460-465.［9］POULIN P, AUSTEN L, SCOTT CM, et al. Multi-criteria development and incorporation into decision tools for health technology adoption［J］. Journal of Health Organization & Management, 2013, 27(2):246-265.［10］LETTIERI E, MASELLA C. Priority setting for technology adoption at a hospital level: Relevant issues from the literature［J］. Health Policy, 2009, 90(1):81-88.［11］MARTELLI N, DEVAUX C, HLNE VDB, et al. Harmonizing health technology assessment practices in university hospitals: to what extent is the mini-hta model suitable in the french context?［J］. International Journal of Technology Assessment in Health Care, 2017,33(2):307-314.［12］李正翔,张玉,张伶俐,等.医疗机构药品遴选指南［J］.中国药房,2022,33(7):769-776.［13］赵志刚,董占军,刘建平.中国医疗机构药品评价与遴选快速指南(第二版)［J］.医药导报,2023,42(4):447-456.［14］国家医保局，人力资源社会保障部.关于印发《国家基本医疗保险、工伤保险和生育保险药品目录（2023年）》的通知：医保发〔2023〕30号［EB/OL］.(2023-12-13)［2024-03-13］.http://www.nhsa.gov.cn/art/2023/12/13/art_104_11673.html.［15］廖子锐,李晓鹤,冯家琪,等.基于德尔菲法的公立综合医院感染性疾病科综合能力建设评价体系构建研究［J］.中国卫生质量管理,2023,30(5):40-44,50.［16］周明华.我国三级公立医院绩效考核结果分析与思考［J］.中国卫生质量管理,2024,31(1):34-37.［17］林海蓓,刘昕,罗莉,等.基于多准则决策分析的公立医院高值医用耗材准入指标及权重研究［J］.中国卫生质量管理,2023,30(11):64-68.

相似文献/References:

[1]袁玉荣,潘修银.2014年宜昌市医疗机构输血情况调查与分析[J].中国卫生质量管理,2015,22(06):104.
[2]吴娜 庄薇* 赵敏慧 厉跃红 郭娜菲.围产期护理质量评价关键指标体系的构建[J].中国卫生质量管理,2016,23(05):056.[doi:10.13912/j.cnki.chqm.2016.23.5.17]
[3]路阳李冬梅陆晨.基于德尔菲法的临床路径动态化考核管理研究[J].中国卫生质量管理,2017,24(02):044.[doi:10.13912/j.cnki.chqm.2017.24.2.15]
[4]陈利娜张丽华.医院创新能力评价指标体系构建研究[J].中国卫生质量管理,2017,24(02):117.[doi:10.13912/j.cnki.chqm.2017.24.2.36]
[5]张晓侠 杨晓蓉 张玉莲.儿科护理敏感质量指标体系的构建[J].中国卫生质量管理,2017,24(06):063.[doi:10.13912/j.cnki.chqm.2017.24.6.21]
[6]杨玉丽 魏海英 王涛 袁萍 马丽.日本医疗机构评审概述及启示[J].中国卫生质量管理,2018,25(05):131.[doi:10.13912/j.cnki.chqm.2018.25.5.38]
[7]龚芳 孙湛.加强医疗技术临床应用事中事后监管的探析[J].中国卫生质量管理,2019,26(01):025.[doi:10.13912/j.cnki.chqm.2019.26.1.09]
[8]归纯漪 孙梅.上海市某三甲专科医院医疗风险相关事件调查分析[J].中国卫生质量管理,2019,26(02):053.[doi:10.13912/j.cnki.chqm.2019.26.2.17]
[9]李前慧 钟源 姜英玉 曾光.智能预诊系统质量评价指标体系的构建研究[J].中国卫生质量管理,2019,26(02):079.[doi:10.13912/j.cnki.chqm.2019.26.2.23]
[10]王川 孙涛.构建研究型医院科技创新能力评价指标体系[J].中国卫生质量管理,2019,26(03):130.[doi:10.13912/j.cnki.chqm.2019.26.3.36]

更新日期/Last Update: 2024-08-15